Market capitalization | $16.98m |
Enterprise Value | $17.39m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.25 |
P/S ratio (TTM) P/S ratio | 0.25 |
P/B ratio (TTM) P/B ratio | 2.32 |
Revenue growth (TTM) Revenue growth | 8.12% |
Revenue (TTM) Revenue | $69.01m |
As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.
2 Analysts have issued a Flora Growth Corp forecast:
2 Analysts have issued a Flora Growth Corp forecast:
Jun '24 |
+/-
%
|
||
Revenue | 69 69 |
8%
8%
|
|
Gross Profit | 4.71 4.71 |
387%
387%
|
|
EBITDA | -5.45 -5.45 |
61%
61%
|
EBIT (Operating Income) EBIT | -6.38 -6.38 |
63%
63%
|
Net Profit | -14 -14 |
79%
79%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: Cultivation, Processing, and Supplying of Natural, Medicinal-Grade Cannabis Oil and High Quality Cannabis; Over-the-Counter Medical Products and Medical Cannabis Products; Wellbeing Products; and Food and Beverage Products. The company was founded on March 13, 2019 and is headquartered in Toronto, Canada.
Head office | Canada |
CEO | Clifford Starke |
Employees | 108 |
Founded | 2019 |
Website | www.floragrowth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.